SHL Telemedicine

Home-based Heart-monitoring Systems

Health Tech & Life Sciences
Public on SIX on Apr, 2000<br>Public on NASDAQ on Mar, 2023<br>

Company Overview

Snapshot

Founded in January 1987 by Yariv Alroy, SHL Telemedicine operates with 51–200 employees. The company has raised a total of $109 million across 3 funding rounds from 3 investors. In March 2023, SHL Telemedicine commenced trading on NASDAQ.

Business overview

SHL Telemedicine develops ECG and supporting devices, platforms, and software for home care, aiming to enhance survival rates and quality of life for individuals after cardiac events. The company's intuitive and compact ECG devices can record 12 hospital-grade ECGs rapidly. Central to its service is a 24/7 telemedicine center staffed by medical professionals, providing evaluation and care. Each user maintains a secure personal health record, including medical history and baseline data. SHL Telemedicine serves the digital healthcare and medical device sectors, focusing on patient remote monitoring, and targets healthcare providers, patients, and insurance companies in markets such as Europe, the United States, Germany, and China.

Strategic signal

In May 2024, SHL Telemedicine expanded its offering in Israel by introducing a groundbreaking at-home biomarker blood test, following the official launch of its SmartHeart Direct-to-Consumer Membership in the US. This strategic move indicates the company's commitment to broadening its direct-to-consumer services and enhancing its diagnostic capabilities, signaling a focus on accessible, home-based healthcare solutions and potential market expansion.

Company Intelligence Q&A

When did SHL Telemedicine go public on NASDAQ?
SHL Telemedicine commenced trading on NASDAQ in March 2023.
What was a significant product expansion for SHL Telemedicine in Israel?
In May 2024, SHL Telemedicine expanded its offering in Israel with a groundbreaking at-home biomarker blood test.
What was a key strategic move for SHL Telemedicine in the US in late 2023?
In November 2023, SHL Telemedicine established a US Nationwide Cardiology Network for ECG interpretations and telehealth visits, and introduced its SmartHeart Direct-to-Consumer Membership Plan in the US.
What was a notable acquisition by SHL Telemedicine in 2021?
In January 2021, SHL Telemedicine acquired Jumedi, a developer of digital health technologies, strengthening its leadership in the field.
What did trials at Mayo Clinic and Imperial College London show about SHL Telemedicine's technology?
In September 2023, trials at Mayo Clinic and Imperial College London demonstrated remarkable effects from SHL Telemedicine's SmartHeart technology.

External links